Technology Platform
R&D and Production Support
Safe and effective
regenerative
therapy and
Cell therapy.
HOME > Technology Platform > R&D and Production Support
R&D test and production bases
ANEXT Shanghai Headquarter R&D Center
ANEXT Anhui
Stem Cell Genetic Engineering Co., Ltd
Shandong Jiekai
Cell Engineering Laboratory
Sinopharm
Chengdu Xinlibang Biopharmaceutical Co.
ANEXT Shanghai Headquarter R&D Center

Main function

The center is ANEXT core technology platform which takes responsibility for innovative drug R&D and pilot, undertakes the company's new drug development and CDMO project research verification, system construction and R&D transformation work.


Scales

1000 square meters of high-standard GMP laboratory + Oriental Beauty Valley Institute of Regenerative Medicine academic platform.


location

Oriental Beauty Vally, Fengxian District, Shanghai.

ANEXT AnhuiStem Cell Genetic Engineering Co., Ltd

Main function

ANEXT exosomes innovative medical device production base, declared and holds the medical device registration certificate and medical device production license, carrying the company's main medical device products scale production work.


Scales

3,000 square meters purification workshop, a full set of medical device production line, the subsequent proposed expansion of the scale of exosome material preparation function.


location

Tongcheng Economic and Technological Development Zone, Anqing City, Anhui Province.

Shandong JiekaiCell Engineering Laboratory

Main function

Highly specific exosome engineering modification and screening laboratory, performing exosome modification, preparation, purification process testing and process validation, pilot production of exosome raw materials.


Scales

600 square meters GMP laboratory.


location

Jinan Bio Valley, Shandong Province.

SinopharmChengdu Xinlibang Biopharmaceutical Co.

Main function

Pilot and industrialization service platform for innovative medicines and biological pharmaceutical products, advanced technology production platform for sterile lyophilized powder injection (including liposome) preparations. Having MAH system services, OEM production, CDMO pilot, drug commissioned production, CMO contract production, drug cooperation declaration and clinical sample preparation.


Scales

A GMP certified (new version) lyophilized powder injection production line. Over 10,000 square meters of research and production facilities.


location

High-tech Zone, Chengdu, Sichuan Province.

Theoretical research and strategic guidance
FITCELL Institute of Medical Research, UK

Main function

Cellular exosome technology direction, R & D strategy and research layout forward planning and guidance, basic theory and research modeling, systematic testing platforms.


Location

Cardiff, England

Laboratory jointly built under strategic cooperation
China General Research Institute of Pharmaceutical Industry, Sinopharm
Main function
Exosome drug intermediates, drug delivery research base, specialized research base for exosome as a vaccine carrier, supporting the industrialization of exosome drug intermediates, the proposed establishment of the most large-scale domestic drug delivery platform pilot base.
State Key Laboratory of Bioreactors, East China University of Science and Technology
Main function
Combined with the bioreactor technology system of East China University of Science and Technology, jointly design and improve the large-scale production process of exosomes, realize the large-scale mass production of exosome materials, and cooperate to build a 10,000 upgraded exosome raw material production base.